SS Innovations International (NASDAQ: SSII) has unveiled its SSi Mantra 3.0 surgical robotic system at Kings Hospital Colombo, establishing Sri Lanka's first robotic cardiac surgery program. The program commenced with a robotic-assisted left internal mammary artery takedown performed by the company's founder and Chairman, Dr. Sudhir Srivastava, alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. According to the announcement, the hospital completed more than 25 robotic procedures within the first three weeks, underscoring the rapid adoption of the technology in a new market.
This launch is part of SS Innovations' broader international expansion strategy. As of the end of the second quarter of 2026, the company reported 224 cumulative SSi Mantra installations across 12 countries. Quarterly revenue increased 39% year over year to $13.9 million, while robotic procedures rose 143% to 2,528. These figures indicate not only growing sales but also increased utilization of installed systems, which could drive recurring revenue from surgical instruments and consumables. The company's focus on making robotic surgery affordable and accessible positions it to capture demand in emerging markets where cost-effective solutions are critical.
SS Innovations is also pursuing regulatory clearances to enter larger markets. U.S. FDA clearance is targeted for the first quarter of 2027, and European CE marking is targeted for the end of 2026. Achieving these milestones would significantly expand the company's addressable market and enhance its competitive position against established robotic surgery players. For a deeper look at the company's prospects, the full article is available at https://nnw.fm/DJ6dI.
Investors and industry observers can find more information on SS Innovations through its website, SSInnovations.com, and stay updated on the latest news and developments via the company's newsroom at https://nnw.fm/SSII. The announcement was distributed through NetworkNewsWire, a communications platform that is part of the Dynamic Brand Portfolio at IBN. NetworkNewsWire provides services including InvestorWire distribution and editorial syndication to 5,000+ outlets, helping companies like SS Innovations reach a wider audience.
The successful launch in Sri Lanka and the company's financial performance suggest that SS Innovations is gaining traction in the global surgical robotics market. With regulatory approvals on the horizon and a growing installed base, the company appears well-positioned to capitalize on the increasing demand for robotic-assisted surgery. As healthcare systems worldwide seek advanced yet affordable solutions, SS Innovations' strategy could yield significant long-term benefits for both patients and shareholders. For full terms and disclaimers, visit https://www.NetworkNewsWire.com/Disclaimer.
